基于放射组学的人工智能方法在乳腺癌诊断和预测方面的应用价值
Radiomics-Based Artificial Intelligence in Breast Cancer: Application Value in Diagnosis and Prediction
DOI: 10.12677/acm.2026.161280, PDF,    科研立项经费支持
作者: 徐稼奇, 徐 扬:绍兴文理学院医学院,浙江 绍兴;章 俞, 韦明珠*:绍兴市人民医院绍兴文理学院附属第一医院放射科,浙江 绍兴;何高燕:绍兴市妇幼保健院放射科,浙江 绍兴
关键词: 乳腺癌放射组学人工智能肿瘤学Breast Cancer Radiomics Artificial Intelligence Oncology
摘要: 乳腺癌是全球女性中最常见的恶性肿瘤,早期发现对降低死亡率至关重要。包括放射影像学检查、临床评估和活检等的传统诊断方法在早期乳腺癌识别中发挥核心作用,但由于影像学筛查的敏感性和阳性预测值不足,同时侵入性组织活检则引发安全性、患者不适及采样偏差等问题的存在使得乳腺癌的早期诊断存在一定的局限性。人工智能与放射组学作为新兴技术,能够从医学影像中提取超越人类视觉感知的高维量化特征。通过整合这些先进计算技术,可构建更精准且可重复的诊断与预测模型。日益增多的证据表明,基于AI和放射组学的方法在提升乳腺癌检测率、预后评估及治疗反应评价方面具有巨大潜力,为推进精准肿瘤学开辟了新路径。
Abstract: Breast cancer is the most commonly diagnosed malignancy among women worldwide, and early detection remains essential for reducing mortality. Conventional diagnostic approaches, including radiological imaging, clinical evaluation, and biopsy, play a central role in early breast cancer identification; however, these methods face notable limitations. Imaging-based screening often demonstrates suboptimal sensitivity and positive predictive value, while invasive tissue biopsy raises concerns regarding safety, patient discomfort, and sampling bias. Artificial intelligence and radiomics have emerged as innovative approaches capable of extracting high-dimensional quantitative features from medical images that exceed human visual perception. By integrating these advanced computational techniques, it is possible to construct more accurate and reproducible diagnostic and predictive models. Growing evidence indicates that AI- and radiomics-based methods hold significant promise in improving breast cancer detection, prognostic assessment, and treatment response evaluation, offering new opportunities to advance precision oncology.
文章引用:徐稼奇, 徐扬, 章俞, 韦明珠, 何高燕. 基于放射组学的人工智能方法在乳腺癌诊断和预测方面的应用价值[J]. 临床医学进展, 2026, 16(1): 2221-2228. https://doi.org/10.12677/acm.2026.161280

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Naji, M.A., Filali, S.E., Aarika, K., Benlahmar, E.H., Abdelouhahid, R.A. and Debauche, O. (2021) Machine Learning Algorithms for Breast Cancer Prediction and Diagnosis. Procedia Computer Science, 191, 487-492. [Google Scholar] [CrossRef
[3] Riggio, A.I., Varley, K.E. and Welm, A.L. (2020) The Lingering Mysteries of Metastatic Recurrence in Breast Cancer. British Journal of Cancer, 124, 13-26. [Google Scholar] [CrossRef] [PubMed]
[4] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[5] Gradishar, W.J., Anderson, B.O., Balassanian, R., Blair, S.L., Burstein, H.J., Cyr, A., et al. (2018) Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 16, 310-320. [Google Scholar] [CrossRef] [PubMed]
[6] Prud'homme, C., Deschamps, F., Allorant, A., Massard, C., Hollebecque, A., Yevich, S., et al. (2018) Image-Guided Tumour Biopsies in a Prospective Molecular Triage Study (MOSCATO-01): What Are the Real Risks? European Journal of Cancer, 103, 108-119. [Google Scholar] [CrossRef] [PubMed]
[7] Li, J., Sheng, D., Chen, J., You, C., Liu, S., Xu, H., et al. (2023) Artificial Intelligence in Breast Imaging: Potentials and Challenges. Physics in Medicine & Biology, 68, 23TR01. [Google Scholar] [CrossRef] [PubMed]
[8] Nolan, E., Lindeman, G.J. and Visvader, J.E. (2023) Deciphering Breast Cancer: From Biology to the Clinic. Cell, 186, 1708-1728. [Google Scholar] [CrossRef] [PubMed]
[9] Hartmann, K., Sadée, C.Y., Satwah, I., Carrillo-Perez, F. and Gevaert, O. (2023) Imaging Genomics: Data Fusion in Uncovering Disease Heritability. Trends in Molecular Medicine, 29, 141-151. [Google Scholar] [CrossRef] [PubMed]
[10] Bi, W.L., Hosny, A., Schabath, M.B., Giger, M.L., Birkbak, N.J., Mehrtash, A., et al. (2019) Artificial Intelligence in Cancer Imaging: Clinical Challenges and Applications. CA: A Cancer Journal for Clinicians, 69, 127-157. [Google Scholar] [CrossRef] [PubMed]
[11] Kuhl, C., Weigel, S., Schrading, S., Arand, B., Bieling, H., König, R., et al. (2010) Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial. Journal of Clinical Oncology, 28, 1450-1457. [Google Scholar] [CrossRef] [PubMed]
[12] Chen, X., Wang, X., Zhang, K., Fung, K., Thai, T.C., Moore, K., et al. (2022) Recent Advances and Clinical Applications of Deep Learning in Medical Image Analysis. Medical Image Analysis, 79, Article ID: 102444. [Google Scholar] [CrossRef] [PubMed]
[13] Yang, X., Wu, L., Zhao, K., Ye, W., Liu, W., Wang, Y., et al. (2020) Evaluation of Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer Using Preoperative Multidetector Computed Tomography with Deep Learning and Handcrafted Radiomics Features. Chinese Journal of Cancer Research, 32, 175-185. [Google Scholar] [CrossRef] [PubMed]
[14] Pesapane, F., Rotili, A., Penco, S., Nicosia, L. and Cassano, E. (2022) Digital Twins in Radiology. Journal of Clinical Medicine, 11, Article 6553. [Google Scholar] [CrossRef] [PubMed]
[15] Li, H., Mendel, K.R., Lan, L., Sheth, D. and Giger, M.L. (2019) Digital Mammography in Breast Cancer: Additive Value of Radiomics of Breast Parenchyma. Radiology, 291, 15-20. [Google Scholar] [CrossRef] [PubMed]
[16] Bickelhaupt, S., Jaeger, P.F., Laun, F.B., Lederer, W., Daniel, H., Kuder, T.A., et al. (2018) Radiomics Based on Adapted Diffusion Kurtosis Imaging Helps to Clarify Most Mammographic Findings Suspicious for Cancer. Radiology, 287, 761-770. [Google Scholar] [CrossRef] [PubMed]
[17] Jiang, X., Xie, F., Liu, L., Peng, Y., Cai, H. and Li, L. (2018) Discrimination of Malignant and Benign Breast Masses Using Automatic Segmentation and Features Extracted from Dynamic Contrast-Enhanced and Diffusion-Weighted MRI. Oncology Letters, 16, 1521-1528. [Google Scholar] [CrossRef] [PubMed]
[18] Li, H., Zhu, Y., Burnside, E.S., Huang, E., Drukker, K., Hoadley, K.A., et al. (2016) Quantitative MRI Radiomics in the Prediction of Molecular Classifications of Breast Cancer Subtypes in the TCGA/TCIA Data Set. NPJ Breast Cancer, 2, Article No. 16012. [Google Scholar] [CrossRef] [PubMed]
[19] Xie, T., Zhao, Q., Fu, C., Bai, Q., Zhou, X., Li, L., et al. (2018) Differentiation of Triple-Negative Breast Cancer from Other Subtypes through Whole-Tumor Histogram Analysis on Multiparametric MR Imaging. European Radiology, 29, 2535-2544. [Google Scholar] [CrossRef] [PubMed]
[20] Jiang, L., You, C., Xiao, Y., Wang, H., Su, G., Xia, B., et al. (2022) Radiogenomic Analysis Reveals Tumor Heterogeneity of Triple-Negative Breast Cancer. Cell Reports Medicine, 3, Article ID: 100694. [Google Scholar] [CrossRef] [PubMed]
[21] Liang, C., Cheng, Z., Huang, Y., He, L., Chen, X., Ma, Z., et al. (2018) An MRI-Based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer. Academic Radiology, 25, 1111-1117. [Google Scholar] [CrossRef] [PubMed]
[22] Ma, W., Ji, Y., Qi, L., Guo, X., Jian, X. and Liu, P. (2018) Breast Cancer Ki-67 Expression Prediction by DCE-MRI Radiomics Features. Clinical Radiology, 73, 909.e1-909.e5. [Google Scholar] [CrossRef] [PubMed]
[23] Yu, Y., Tan, Y., Xie, C., Hu, Q., Ouyang, J., Chen, Y., et al. (2020) Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients with Early-Stage Breast Cancer. JAMA Network Open, 3, e2028086. [Google Scholar] [CrossRef] [PubMed]
[24] Yu, Y., He, Z., Ouyang, J., Tan, Y., Chen, Y., Gu, Y., et al. (2021) Magnetic Resonance Imaging Radiomics Predicts Preoperative Axillary Lymph Node Metastasis to Support Surgical Decisions and Is Associated with Tumor Microenvironment in Invasive Breast Cancer: A Machine Learning, Multicenter Study. eBioMedicine, 69, Article ID: 103460. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, H., Zou, L., Xu, N., Shen, H., Zhang, Y., Wan, P., et al. (2024) Deep Learning Radiomics Based Prediction of Axillary Lymph Node Metastasis in Breast Cancer. npj Breast Cancer, 10, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[26] Cattell, R., Ying, J., Lei, L., Ding, J., Chen, S., Serrano Sosa, M., et al. (2022) Preoperative Prediction of Lymph Node Metastasis Using Deep Learning-Based Features. Visual Computing for Industry, Biomedicine, and Art, 5, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
[27] Choudhery, S., Gomez-Cardona, D., Favazza, C.P., Hoskin, T.L., Haddad, T.C., Goetz, M.P., et al. (2022) MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Academic Radiology, 29, S145-S154. [Google Scholar] [CrossRef] [PubMed]
[28] Li, W., Huang, Y., Zhu, T., Zhang, Y., Zheng, X., Zhang, T., et al. (2024) Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden during Neoadjuvant Chemotherapy in Breast Cancer. Annals of Surgery, 281, 645-654. [Google Scholar] [CrossRef] [PubMed]
[29] Zhu, T., Huang, Y., Li, W., Zhang, Y., Lin, Y., Cheng, M., et al. (2023) Multifactor Artificial Intelligence Model Assists Axillary Lymph Node Surgery in Breast Cancer after Neoadjuvant Chemotherapy: Multicenter Retrospective Cohort Study. International Journal of Surgery, 109, 3383-3394. [Google Scholar] [CrossRef] [PubMed]
[30] Friedman, J.H. (2001) Greedy Function Approximation: A Gradient Boosting Machine. The Annals of Statistics, 29, 1189-1232. [Google Scholar] [CrossRef
[31] Lundberg, S.M. and Lee S.I. (2017) A Unified Approach to Interpreting Model Predictions. arXiv: 1705.07874.
[32] Iqbal, S., Qureshi, A.N., Alhussein, M., Aurangzeb, K. and Anwar, M.S. (2024) AD-CAM: Enhancing Interpretability of Convolutional Neural Networks with a Lightweight Framework from Black Box to Glass Box. IEEE Journal of Biomedical and Health Informatics, 28, 514-525. [Google Scholar] [CrossRef] [PubMed]
[33] Barnett, A.J., Schwartz, F.R., Tao, C., Chen, C., Ren, Y., Lo, J.Y., et al. (2021) A Case-Based Interpretable Deep Learning Model for Classification of Mass Lesions in Digital Mammography. Nature Machine Intelligence, 3, 1061-1070. [Google Scholar] [CrossRef